Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 289-632-8 | CAS number: 89958-10-1 Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Bulnesia sarmienti, Zygophyllaceae.
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 18-12-2015 to 25-03-2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- in accordance with GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- Bulnesia sarmienti, ext.
- EC Number:
- 289-632-8
- EC Name:
- Bulnesia sarmienti, ext.
- Cas Number:
- 89958-10-1
- Molecular formula:
- This reference substance is a UVCB of the NCS type. It is a complex mixture of compounds and therefore molecular formula, molecular weight, and structural formula canoot be given.
- IUPAC Name:
- Essential oil of Guaiacwood obtained from the wood of Bulnesia sarmientoi by steam distillation
- Test material form:
- liquid: viscous
- Details on test material:
- - Name of test material (as cited in study report): Guaiacwood oil
- Physical state: viscous liquid
- Storage condition of test material: at room temperature protected from light
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: approximately 10 weeks old
- Weight at study initiation: body weight variation was within +/- 20% of the sex mean
- Housing: labeled Makrolon cages containing sterilised sawdust as bedding material. Paper and shelters were supplied as cage-enrichment
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days before the start of treatment under laboratory conditions
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18 to 24°C
- Humidity (%): 40 to 70%
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12 hrs dark/ 12 hrs light
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Pre-screen test: 50 - 100%Main study: 0 - 25 - 50 -100 % (v/v)
- No. of animals per dose:
- 5
- Details on study design:
- MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Criteria used to consider a positive response: Increased T-lymphocyte proliferation in the test groups as compared to the concurrent vehicle control group.
EVALUATION
The disintegrations per minute (dpm) value was determined for each test group. This information was used to calculate the Stimulation Index (SI) for each of the test groups (disintegrations per minute of treatment group / disintegrations per minute of control group). A positive response is indicated when one or more test groups shows a SI of 3. The EC3 value is the concentration at which a 3-fold increase of lymph node proliferation is observed. Interpolation is used to determine the EC3 value between two test concentrations (based on the following reference: Basketter DA, Lea LJ, Dickens A, Briggs, D, Pate I, Dearman RJ and Kimber I.A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J Appl Toxicol 1999; 19:261-266 - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The six monthly reliability check with Hexylcinnamaldehyde, indicates that the Local Lymph Node Assay as performed at WIL Research Europe is an appropriate model for testing for contact hypersensitivity.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- EC3
- Value:
- 42.6
- Parameter:
- SI
- Value:
- 1.8
- Test group / Remarks:
- 25%
- Parameter:
- SI
- Value:
- 3.5
- Test group / Remarks:
- 50%
- Parameter:
- SI
- Value:
- 4.4
- Test group / Remarks:
- 100%
- Cellular proliferation data / Observations:
- CELLULAR PROLIFERATION DATA
Mean DPM/animal values for the experimental groups treated with test substance concentrations 25, 50 and 100% were 1116, 2158 and 2746 DPM respectively.
The mean DPM/animal value for the vehicle control group was 623 DPM.
DETAILS ON STIMULATION INDEX CALCULATION
The Stimulation Index was calculated as a ratio of the DPM from test groups and the DPM vehicle control group (DPM test group / DPM vehicle control group).
EC3 CALCULATION
The data showed a dose-response relationship and an EC3 value (the estimated test substance concentration that will give a SI =3) of 42.6% was calculated.
CLINICAL OBSERVATIONS:
The results of the LLNA study showed that no irritation was observed in any of the animals. Scaliness was noted for three animals treated at 50% and all animals treated at 100% on Day 6. The relative size of the auricular lymph nodes of all animals of the experimental and control groups were considered normal in size. There was no mortality, neither where there any clinical signs of systemic toxicity.
BODY WEIGHTS
Body weights and body weight gain of experimental animals remained in the same range as controls over the study period.
Any other information on results incl. tables
Pre-screen test: The results of the epidermal exposures for the selection of highest test substance concentration show that there was no clear irritation detected, apart from very slight erythema (barely perceptible). Based on these results, the highest test substance concentration selected for the main study was a 100% concentration.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Conclusions:
- Under the conditions of this test, the test substance was found to elicit a positive response (SI ≥ 3) and a clear dose-response relationship was found. The EC3 value was calculated to be 42.6%. Based on these results, Guaiacwood oil needs to be classified for skin sensitization (H317, Skin Sens. 1B) in accordance with the criteria outlined in Annex I of CLP (1272/2008/EC).
- Executive summary:
The Local Lymph Node Assay (according to OECD 429) was conducted to determine the sensitising potential of Guaiacwood oil in mice. Lymph node proliferation was determined after exposure to 0%, 25%, 50% or 100% Guaiacwood oil in vehicle (Acetone/Olive oil (4:1 v/v)), using radioactivity counts (DPM). A pooled approach (per test group) was used. Stimulation indices were calculated.
Measured disintegrations per node (pooled) were 623, 1116, 2158 and 2746 for the 0%, 25%, 50% and 100% dosing groups, respectively. Corresponding stimulation indices (SI) were calculated to be 1.8, 3.5 and 4.4 for the 25%, 50% and 100% concentration, respectively. The EC3 was calculated to be 42.6%. Based on these results, Guaiacwood oil needs to be classified for skin sensitization (H317, Skin Sens. 1B) in accordance with the criteria outlined in Annex I of CLP (1272/2008/EC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.